Supriya Lifescience Stock Analysis: Revenue Grows 10% CAGR; Margins At 38% | Know Your Company

Know Your Company | In this episode of Know Your Company, we are focussing on Supriya Lifescience. The company is majorly focused in actively manufacturing APIs. Pricing pressure in API market? It has 40+ APIs with presence over 120+ countries. More than 18 products are backward integrated. Competitive landscape and scale-up in CDMO? 20% growth conservative? Scope for margin expansion? What are the company's expansion plans? We discuss all this and the company's growth outlook with Satish Waman Wagh, Chairman, Supriya Lifescience. #supriyalifescience #pharmasector #knowyourcompany For more videos subscribe to our channel:    / @ndtvprofitindia   Visit NDTV Profit for more news: https://www.ndtvprofit.com/ Don't enter the stock market unaware. Read all Research Reports here: https://www.ndtvprofit.com/research-r... Follow NDTV Profit here Twitter:   / ndtvprofitindia   ,   / ndtvprofit   LinkedIn:   / ndtvprofit   Instagram:   / ndtvprofit   Facebook:   / ndtvprofit